The market for automated cell culture systems worldwide is anticipated to grow from a US$10.91 billion valuation in 2022 to a US$20.87 billion valuation by 2030, expanding at a high CAGR of 8.4%.

Automated Cell Culture Systems Market Size (2022)US$ 10.91 BnRevenue Forecast (2030)US$ 20.87 BnGlobal Market Growth Rate (2022–2030)8.4% CAGREurope Marker Share35.7%

At the moment, automated cell culture systems hold a 44.5% market share worldwide. Increased investments in the creation of cutting-edge products as well as rising stem cell research and development are driving the growth of the automated cell culture systems market.

Additionally, 3D cell cultures, which were previously difficult and expensive, are now possible thanks to the development of spheroids.

Additionally, because of the hypoxic core and nutrient gradient, they more closely resemble tumours.

In order to facilitate drug screenings, researchers from the US and Germany have developed a protocol for growing 3D cultures of commonly used cancer cells.

These elements will keep North America and Europe on top of the market for automated cell culture systems.

Furthermore, despite the pandemic-caused economic downturn, the automated cell culture market will benefit from the need for cell lines for developing vaccines against the COVID-19 infection.

Key Takeaways from Automated Cell Culture Systems Market

• Consumables are expected to reach US$ 11 Bn by 2030
• Academic institutes are expected to take greater interests in research related to cell culture over the forecast period due to increased government funding in developed countries
• North America and Europe collectively accounted for more than 60% of market share in 2019
• Infinite cell line cultures held close to 75% of market share in 2019

Automated Cell Culture Systems Market: Competitive Insights

The increasing drug discovery research and various cell line applications in research are expected to drive the growth of the global automated cell culture systems market during the forecast period.

Automated cell culture systems are also employed in experiments for cell banking and drug discovery research. The adoption of automated cell culture systems is also being boosted by cost effectiveness and an increase in alternatives to conventional cell culture production.

New Product Launches to Remain Key Strategic Focus of Market Players

Key players:

• Thermo Fisher Scientific
• Corning Incorporated
• Merck KGaA
• Lonza
• Sartorius AG
• Tecan Trading AG
• Hamilton Medical AG.
• Biospherix and Promocell GmbH.

Players in automated cell culture systems market are focusing on new product launches for expanding their global footprint and strengthening product portfolio.

For instance –

• In Jun 2020, faCellitate announced launching “BIOFLOAT”, its very first product to improve 3D cell culture.
• In Mar 2020, BioProcess International started implementing single-use miniature bioreactors for supporting intensified cell culture by using functional performance indicators for assessing small-scale model
• Corning Incorporated, in Oct 2019, came up with Corning Elplasia Plates and Matrigel for organoid culture. It was an addition to its 3D cell culture portfolio
• Ori Biotech has started developing an automated way of manufacturing cell and gene therapies
• In May, 2020, Sartorius announced launch of the Incucyte SX5® for live-cell analysis, for live-cell analysis experiments

Key Segment

Product Type

• Automated Cell Culture Storage Equipment
• Automated Cell Culture Vessels
• Bioreactors
• Consumables

Cell Culture Type

• Finite Cell Line Cultures
• Infinite Cell Line Cultures

Application

• Drug Development
• Stem Cell Research
• Regenerative Medicine
• Cancer Research

End User

• Biotech Companies
• Research Organizations
• Academic Institutes

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

Information Source:
https://www.futuremarketinsights.com/reports/automated-cell-culture-systems-market